{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-011379","form_type":"8-K","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2023-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.342865+00:00","generated_at":"2026-06-16T09:12:27.191640+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Reviva grants stock options to CEO, CFO, and VP; 1.303M shares total","bullets":["CEO Dr. Bhat granted option for 443,000 shares; CFO Prabhu for 170,000 shares.","VP Seema Bhat (CEO's spouse) granted option for 150,000 shares.","Options vest 50% immediately, then 1.389% monthly; exercise price $6.74.","Additional 540,000 options awarded to other employees under 2020 Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-011379","json":"https://secwatch.observer/filing/0001437749-23-011379.json","markdown":"https://secwatch.observer/filing/0001437749-23-011379.md","text":"https://secwatch.observer/filing/0001437749-23-011379.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774923011379/0001437749-23-011379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774923011379/rvph20230426_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T09:12:27.191640+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}